neoplasia News and Research

RSS

Study suggests active surveillance over instant treatment for some cervical lesions

A new study suggests that regular monitoring (“active surveillance”) instead of instant treatment can prove effective for moderate cervical lesions–unusual cells on the cervix surface, typically known as cervical intra-epithelial neoplasia grade 2 or CIN2.

28 Feb 2018

Specific protein negatively affects pancreatic cells and leads to cancer growth

Pancreatic cancer is one of the most aggressive forms of cancer and is currently very difficult to treat. However, the last few years have seen advances in the scientific understanding of how this cancer develops at a molecular level.

6 Dec 2017

New molecule demonstrates ability to block lymphoma growth

The prestigious scientific journal Clinical Cancer Research has published a study conducted by the research group led by Dr. Francesco Bertoni of the Institute of Oncology Research, that have tested a new molecule that demonstrates its ability to inhibit lymphoma growth.

28 Nov 2017

Researchers develop new tool to share clinico-genomic data

Researchers from Universidad Politécnica de Madrid have developed a new tool that provides standard and shared clinico-genomic data among European healthcare institutions.

20 Nov 2017

New studies provide insight into treatments for Barrett's esophagus

The October issue of GIE: Gastrointestinal Endoscopy features several new studies evaluating various treatments for Barrett's esophagus (BE). Two of these studies are highlighted below. BE is a condition in which there are unusual changes to the cells lining the esophagus. It is believed to be most commonly due to inflammation from gastroesophageal reflux disease (GERD).

6 Oct 2017

Good-guy bacteria may help individuals respond well to cancer immunotherapy

Individuals with certain types of bacteria in their gut may be more likely to respond well to cancer immunotherapy, researchers at the Harold C. Simmons Comprehensive Cancer Center found in a study of patients with metastatic melanoma.

5 Oct 2017

Notre Dame's HCRI publishes two papers involving ovarian cancer research

Two papers involving ovarian cancer research at the University of Notre Dame's Harper Cancer Research Institute, one featuring new research and the other a review article, were published as cover stories in their respective journals.

27 Sep 2017

ClearLLab reagents to aid the detection of leukemia and lymphoma receive FDA clearance

Beckman Coulter welcomes FDA announcement for received regulatory clearance to market its ClearLLab reagents for in vitro diagnostic use in the US.

From Beckman Coulter Life Sciences - Flow Cytometry 14 Jul 2017

MSTF recommends colonoscopy and FIT as first tier screening tests for colorectal cancer

In its latest recommendations, the US Multi-Society Task Force on Colorectal Cancer Screening confirms that people at average risk should be screened beginning at age 50, and recommends colonoscopy and fecal immunochemical testing as the "first tier" screening tests for this group.

21 Jun 2017

Study finds decline in rates of HPV-related precancerous cervical lesions among women in Connecticut

The vaccine for the Human Papillomavirus is proving to have significant population-level effects in Connecticut, with rates of precancerous lesions caused by HPV down drastically among young women, a new Yale School of Public Health study finds.

31 May 2017

Artificial intelligence image detection technique offers low-cost, improved screening for cervical cancer

Artificial intelligence--commonly known as A.I.--is already exceeding human abilities. Self-driving cars use A.I. to perform some tasks more safely than people. E-commerce companies use A.I. to tailor product ads to customers' tastes quicker and with more precision than any breathing marketing analyst.

24 Apr 2017

Scientists uncover how tumor cells can switch disguises to spread easily around the body

Scientists have uncovered how tumor cells in aggressive uterine cancer can switch disguises and spread so quickly to other parts of the body.

30 Mar 2017

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

City of Hope, a world-renowned independent research and cancer and diabetes treatment center, will highlight a variety of basic research and population studies at the annual meeting of the American Association for Cancer Research at the Walter E. Washington Convention Center in Washington, D.C., April 1 to 5.

28 Mar 2017

Scientists devise novel DNA vaccine approach against important cancer antigen targets

Scientists at The Wistar Institute and Inovio Pharmaceuticals, Inc. have devised a novel DNA vaccine approach through molecular design to improve the immune responses elicited against one of the most important cancer antigen targets. Study results were published in the journal Molecular Therapy.

24 Feb 2017

Researchers show how metabolism drives proliferation of tumor cells

The metabolic state of tumor cells contributes to signals that control the proliferation of tumor cells. Already the German biochemist and Nobel Prize laureate Otto H. Warburg observed in the 1920s that tumor cells radically change their metabolism.

20 Feb 2017

Scientists identify structure of androgenic receptor essential to fight against prostate cancer

A team led by researchers of the Institute of Biomedicine of the University of Barcelona and the Research Institute of the Hospital de la Santa Creu i Sant Paushows for the first time, the three-dimensional structure of the homodimeric androgen receptor ligand-binding domain, a structure that eluded researchers for years.

6 Feb 2017

Testing for Lynch syndrome: an interview with Kevin Monahan

Lynch syndrome is an inherited condition which causes about 1,100 cases of bowel cancer and 1,000 other cancers annually in the UK. It is caused by a fault in the mismatch repair gene (MMR) which usually works to prevent cancer.

21 Nov 2016

Pioneering diagnostic system for cervical cancer to be on display at MEDICA 2016

A pioneering diagnostic system that is having a significant impact on the changing clinical pathway for cervical cancer will be on display at MEDICA 2016 by multi-award winning company, Zilico Ltd.

From Zilico 3 Nov 2016

Beckman Coulter Life Sciences introduces ClearLLab LS Lymphoid Screen Reagent for faster L&L analysis

Beckman Coulter Life Sciences further demonstrates its expertise in clinical flow cytometry with the launch of ClearLLab LS Lymphoid Screen Reagent, Europe’s first CE-marked 10-colour, 12 antibody reagent combination for leukaemia and lymphoma analysis.

20 Oct 2016

HPV vaccine can decrease incidence of cervical pre-cancers among young women, research shows

Every 20 minutes, someone in the United States receives a cancer diagnosis related to human papillomavirus. HPV causes cancer of the cervix, anus and throat.

29 Sep 2016